Investigating the Neuronal Bases of Epilepsy With Micro-electrode Arrays in Candidates for Epilepsy Surgery (IN-MAP)

This is an interventional basic science trial for Epilepsy focused on measuring Epilepsy surgery, Micro-electrode arrays, Single-neuron recordings, Electrocorticography Read More

Inclusion Criteria:

• Patient 18 years old or older
• Patient who suffers from potentially surgically remediable drug-resistant focal epilepsy
• Patient in whom neocortical resective surgery is deemed likely
• Patient who requires evaluation with intracranial subdural EEG electrodes
• Patient in whom a cortical area that is not eloquent (i.e. not involved in a critical neurological function like language or motor control) is deemed highly likely to be involved in seizure onset or propagation and is therefore an appropriate site for the implantation of the micro-electrode array
• Patient who is able and willing to provide informed consent

Exclusion Criteria:

• Patient in whom neocortical resective surgery is deemed unlikely (e.g. patients in whom a corpus callosotomy or another palliative epilepsy surgery procedure is planned)
• Patient who will be investigated with stereo-EEG electrodes only (these patients will not undergo a craniotomy for clinical purposes, and implantation of the micro-electrode array is therefore impossible)
• Patient whose epileptic seizures cause hypermotor or violent motor behavior (due to the risk of MD mechanical failure and related injury)
• Patient with a previous history of bacterial meningitis (due to the risk of thickening of the arachnoid membrane complicating the implantation of the micro-electrode array)
• Patient with severe psychiatric disease or psychological distress
• Patient with severe concomitant medical disease (including, but not limited to, cardiovascular disease, respiratory illness, renal failure, hepatic dysfunction, etc.)
• Patient with known compromise of the immune system caused by a medical condition or the chronic consumption of immunosuppressant medication (due to the increased risk of infection; this includes diabetes mellitus)
• Patient with colonization with methicillin-resistant Staphylococcus aureus (due to the increased risk of difficult-to-manage infection)
• Patient with known tendency for increased bleeding (due to the increased risk of hemorrhage)
• Patient with an implanted intracranial stimulator, vagus nerve stimulator, or cochlear implant that will remain active during the study (due to the potential for interference with the micro-electrode recordings)
• Women who are pregnant or breastfeeding during the study